: Eye care professionals should have access to high quality clinical practice guidelines that ideally are underpinned by evidence from robust systematic reviews of relevant research. The aim of this study was to identify clinical guidelines with recommendations pertaining to dietary modification and/or nutritional supplementation for age-related macular degeneration (AMD), and to evaluate the overall quality of the guidelines using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. We also mapped recommendations to existing systematic review evidence. A comprehensive search was undertaken using bibliographic databases and other electronic resources for eligible guidelines. Quality appraisal was undertaken to g...
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In ...
BACKGROUND: In the absence of a cure, there has been considerable interest in attempts to prevent or...
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in ...
Eye care professionals should have access to high quality clinical practice guidelines that ideally ...
© The Author(s) 2017. Age-related macular disease (AMD) is a multifactorial degenerative condition a...
Age-related macular disease (AMD) is a multifactorial degenerative condition affecting the central a...
The aim of this paper is to summarize all available evidence from systematic reviews, randomized con...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. Despi...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the developed w...
Purpose: To summarise the results of recent Cochrane systematic reviews that have investigated wheth...
Lene Martin1,2 1School of Health, Care and Social Welfare, Mälardalen University, Eskilstuna, S...
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In ...
BACKGROUND: In the absence of a cure, there has been considerable interest in attempts to prevent or...
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in ...
Eye care professionals should have access to high quality clinical practice guidelines that ideally ...
© The Author(s) 2017. Age-related macular disease (AMD) is a multifactorial degenerative condition a...
Age-related macular disease (AMD) is a multifactorial degenerative condition affecting the central a...
The aim of this paper is to summarize all available evidence from systematic reviews, randomized con...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. Despi...
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Ey...
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the developed w...
Purpose: To summarise the results of recent Cochrane systematic reviews that have investigated wheth...
Lene Martin1,2 1School of Health, Care and Social Welfare, Mälardalen University, Eskilstuna, S...
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In ...
BACKGROUND: In the absence of a cure, there has been considerable interest in attempts to prevent or...
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in ...